Rapid CTA

RapidAI

Product specifications Information source: Public
Last updated: Dec. 10, 2022
General
Product name Rapid CTA
Company RapidAI
Subspeciality Neuro
Modality CT
Disease targeted Stroke
Key-features
Suggested use
Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time
Certification
CE
Certified, Class IIa , MDD
FDA
510(k) cleared, Class II
Market presence
On market since 03-2018
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance

  • Machine-learning algorithm in acute stroke: real-world experience (read)

  • Positive predictive value and stroke workflow outcomes using automated vessel density (RAPID-CTA) in stroke patients: One year experience (read)

Non-peer reviewed papers on performance
Other relevant papers